Steve Gallinger

Author PubWeight™ 61.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International network of cancer genome projects. Nature 2010 20.35
2 Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007 6.00
3 Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002 5.91
4 Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 3.99
5 Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 2009 2.56
6 Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol 2012 1.88
7 Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013 1.55
8 Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005 1.46
9 An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007 1.11
10 Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res 2010 1.05
11 A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev 2014 1.03
12 Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Can J Surg 2009 1.01
13 Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012 1.00
14 Predictors of multivisceral resection in patients with locally advanced colorectal cancer. Ann Surg Oncol 2008 1.00
15 Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer. Hum Mol Genet 2013 1.00
16 Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer 2008 0.98
17 Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol 2012 0.97
18 Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res 2010 0.96
19 Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab 2009 0.95
20 The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009 0.91
21 Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol 2013 0.91
22 Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer 2010 0.84
23 Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Fam Cancer 2013 0.83
24 Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Ann Surg Oncol 2012 0.82
25 Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2013 0.81
26 The FAP self-concept scale (adult form). Fam Cancer 2008 0.80
27 Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology 2011 0.80
28 Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep 2015 0.76
29 Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. Histopathology 2014 0.76
30 Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One 2015 0.75
31 Juvenile polyposis syndrome, SMAD4 mutations, and hereditary hemorrhagic telangiectasia. J Pediatr Gastroenterol Nutr 2012 0.75